- Home
- KROS vs ACIC Comparison
KROS vs ACIC Comparison
Compare KROS & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- ACIC
- Stock Information
- Founded
- KROS 2015
- ACIC 1999
- Country
- KROS United States
- ACIC United States
- Employees
- KROS N/A
- ACIC N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- ACIC Property-Casualty Insurers
- Sector
- KROS Health Care
- ACIC Finance
- Exchange
- KROS Nasdaq
- ACIC Nasdaq
- Market Cap
- KROS 460.6M
- ACIC 588.1M
- IPO Year
- KROS 2020
- ACIC N/A
- Fundamental
- Price
- KROS $11.00
- ACIC $11.92
- Analyst Decision
- KROS Buy
- ACIC Buy
- Analyst Count
- KROS 11
- ACIC 1
- Target Price
- KROS $45.33
- ACIC $16.00
- AVG Volume (30 Days)
- KROS 2.1M
- ACIC 156.1K
- Earning Date
- KROS 02-26-2025
- ACIC 02-27-2025
- Dividend Yield
- KROS N/A
- ACIC 4.18%
- EPS Growth
- KROS N/A
- ACIC N/A
- EPS
- KROS N/A
- ACIC 1.76
- Revenue
- KROS $651,000.00
- ACIC $290,784,000.00
- Revenue This Year
- KROS $303.27
- ACIC N/A
- Revenue Next Year
- KROS N/A
- ACIC $12.68
- P/E Ratio
- KROS N/A
- ACIC $6.77
- Revenue Growth
- KROS 8037.50
- ACIC 1.02
- 52 Week Low
- KROS $9.78
- ACIC $8.82
- 52 Week High
- KROS $73.00
- ACIC $15.08
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- ACIC 38.97
- Support Level
- KROS $11.04
- ACIC $11.81
- Resistance Level
- KROS $11.99
- ACIC $12.66
- Average True Range (ATR)
- KROS 0.60
- ACIC 0.32
- MACD
- KROS 1.20
- ACIC 0.00
- Stochastic Oscillator
- KROS 43.99
- ACIC 10.38
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.